| Literature DB >> 31349136 |
Marco Cozzolino1, Luca Pesce1, Denise Pezzuoli2, Chiara Montali2, Lorenzo Brancaleon3, Luigi Cavanna4, Stefania Abbruzzetti2, Alberto Diaspro1, Paolo Bianchini5, Cristiano Viappiani6.
Abstract
The spectral and the photophysical properties of phthalocyanines have made these dyes attractive for applications in photodynamic therapy of cancer. One important known issue of these compounds is their tendency to aggregate in aqueous media, which decreases their fluorescence, triplet, and singlet oxygen quantum yields. We report on the use of apomyoglobin as a carrier for zinc phthalocyanine (ZnPc) to overcome solubility limitations of the dye. We show that the protein is able to bind ZnPc in monomeric form, preserving its photophysics. Confocal fluorescence imaging of PC3 and HeLa cells, treated with the complex between ZnPc and apomyoglobin, demonstrates that the photosensitizer is uptaken quickly by cells. Illumination of treated cells strongly decreases viability, as demonstrated by live/dead fluorescence assay.Entities:
Keywords: Drug delivery; Drug uptake kinetics; Live cell fluorescence microscopy; Photodynamic therapy
Mesh:
Substances:
Year: 2019 PMID: 31349136 DOI: 10.1016/j.bpc.2019.106228
Source DB: PubMed Journal: Biophys Chem ISSN: 0301-4622 Impact factor: 2.352